Category
Immune & inflammation
Thymic peptides and anti-inflammatory fragments. A small group with a partial trial record and no FDA-approved product.
What the record holds for this category
5
Compounds tracked
0
With an FDA-approved product
2
With no registered human study
64
Registered studies, all members
Every compound in this category
Ordered by how many people read the Wikipedia article each month, which measures attention and nothing else. The evidence column is what is actually known.
| Compound | FDA status | Human studies | Evidence | Readership |
|---|---|---|---|---|
| Vasoactive intestinal peptide | Research only | 9 | BReached phase 3 or 4, not approved | 2,112 |
| Thymosin alpha-1 | Research only | 50 | BReached phase 3 or 4, not approved | 54 |
| LL-37 | Research only | 5 | CPhase 1 or 2 only | 47 |
| KPV | Research only | 0 | XNo registered human study | — |
| Thymalin | Research only | 0 | XNo registered human study | — |
Compare within this category
These pairs are the most-read members, picked mechanically. Pairing is not a recommendation and says nothing about which is preferable.
Reading on these compounds
Categories are editorial groupings by mechanism — they are not medical classifications, and membership is not a claim that a compound does what the group name suggests. Study counts include only trials whose registered intervention names the compound. Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. How this is put together.